Related Experiment Video
Updated: Aug 30, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
"Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with
Ladan Mansouri1, Senka Sendic2, Sebastian Havervall3
1Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden. Ladan.Mansouri@ki.se.
Insights
Chronic kidney disease patients face higher COVID-19 mortality. Key immune factors like BAFF and sCD25, not just kidney function, predict COVID-19 death risk.
Area of Science:
- Immunology
- Nephrology
- Virology
Background:
- Chronic kidney disease (CKD) is a known risk factor for severe COVID-19 outcomes.
- Understanding the interplay between kidney function, immune response, and COVID-19 mortality is crucial.
Purpose of the Study:
- To investigate the association between kidney function, T and B lymphocyte modulatory factors, and mortality risk in COVID-19 patients.
- To identify specific immune markers that predict mortality in COVID-19.
Main Methods:
- Analysis of in-hospital and 30-day mortality in 110 COVID-19 patients.
- Measurement of plasma levels of T and B cell modulators (e.g., BAFF, sCD25, sPD-L1).
- Subgroup analysis comparing COVID-19 patients with CKD patients and healthy controls.
Main Results:
- Higher BAFF and sCD25 plasma levels were observed in non-survivors.
- Elevated BAFF, sCD25, and sPD-L1 levels correlated with increased in-hospital and 30-day mortality risk.
- Kidney function (eGFR) was not directly associated with mortality risk in logistic regression models.
Conclusions:
- Kidney function and specific immune modulators (BAFF, sCD25, PD-L1) are associated with COVID-19 mortality, independent of traditional risk factors.
- These findings highlight the role of the adaptive immune system in COVID-19 prognosis.
- Further research into these immune modulators may reveal new prognostic and therapeutic strategies for COVID-19.
Background:
Chronic kidney disease (CKD) is a recognized risk factor for severe complications in COVID-19. Our objective was to analyze the association between kidney function / T and B lymphocyte modulatory factors and risk of mortality in COVID-19 patients.
Methods:
In-hospital and 30-day mortality were analyzed in COVID-19 patients (n = 110). Plasma levels of selected T and B cell modulators were analyzed and correlated to mortality risk. A subgroup of sex- and eGFR-matched COVID-19 patients was compared to CKD patients without infection and healthy subjects.
Results:
COVID-19 patients who died in hospital and within 30 days had significantly higher BAFF and sCD25 plasma levels than survivors. In logistic regression models patients with high BAFF, sCD25 and sPD-L1 levels had significantly higher risk of both in-hospital and 30-day mortality while there was no association to eGFR. In the subgroup analysis, a higher level of BAFF, IFN-α, sCD25, sPD-L1 and a lower level of sCD40L was observed in COVID-19 patients compared to the CKD group with corresponding kidney function.
Conclusions:
We demonstrate that kidney function and concentrations of BAFF, sCD25 and PD-L1, independent of previously recognized risk factors; age, male gender, and leukocytosis are associated with risk of in-hospital and 30-day mortality in patients with COVID-19. These data indicate the significance of adaptive immune system modulators in COVID-19 and motivate further analysis to identify new potential prognostic and therapeutic approaches.
More Related Videos
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction